3D Bioprinting Technologies: Patents, Innovation, and Access

6(2) Law, Innovation and Technology 282-304

26 Pages Posted: 2 Oct 2015 Last revised: 17 Oct 2015

See all articles by Phoebe Li

Phoebe Li

University of Sussex Law School

Date Written: 2014

Abstract

Following on from digitisation in production which transforms traditional business models of manufacturing, 3D printing has been extending its application into biotechnology by means of regenerative medicine and tissue engineering. The practice of printing living human cells challenges existing legal frameworks of bioethics, product liability and intellectual property. This article examines the impacts and implications of associated patents arising from 3D bioprinting, specifically by examining the patentability, the morality test, and the medical treatment exception. It considers the consequences of granting 3D bioprinting product and process patents and examines the corresponding rights and responsibilities of stakeholders. In order to implement the benefit-sharing responsibility embedded in international law, this paper proposes a portfolio approach to innovation, with a view to avoiding inequality and disparities in access to 3D bioprinting technologies.

Keywords: 3D printing; 3D bioprinting; Patentability; Methods for medical treatment; Regenerative medicine

JEL Classification: K11

Suggested Citation

Li, Phoebe, 3D Bioprinting Technologies: Patents, Innovation, and Access (2014). 6(2) Law, Innovation and Technology 282-304. Available at SSRN: https://ssrn.com/abstract=2667904

Phoebe Li (Contact Author)

University of Sussex Law School ( email )

Falmer
Brighton BN1 9QN
United Kingdom

HOME PAGE: http://www.sussex.ac.uk/profiles/305243

Register to save articles to
your library

Register

Paper statistics

Downloads
194
Abstract Views
1,071
rank
155,351
PlumX Metrics